drugset / Trial / NCT03789032
Study to Evaluate the Effect of Rabeprazole on the Pharmacokinetics of Vadadustat
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 1, fixed sequence, open-label study to evaluate the effect of multiple oral doses of rabeprazole on the pharmacokinetics of a single dose of vadadustat 300 mg in healthy male and female subjects.
Timeline
- Start
- 2018-10-03
- Primary completion
- 2018-11-09
- Completion
- 2018-11-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rabeprazole | Small molecule | 20 mg | Oral |
| Subject | Vadadustat | Small molecule | 300 mg | — |
Indications
No indication recorded.